particip
children
enrol
us
center
diseas
control
prevent
etiolog
pneumonia
commun
epic
studi
epic
studi
popul
enrol
criteria
specimen
collect
etiolog
test
describ
detail
patient
includ
live
catchment
area
hospit
cap
defin
acut
infect
acut
respiratori
ill
radiograph
confirm
pneumonia
exclus
criteria
includ
recent
hospit
sever
immunosuppress
analysi
univers
utah
irb
cdc
irb
includ
children
n
cap
asymptomat
pediatr
control
subject
age
year
enrol
primari
children
hospit
salt
lake
citi
utah
tabl
patient
enrol
januari
june
control
subject
n
sameday
elect
surgeri
patient
enrol
februari
june
control
subject
respiratori
symptom
fever
within
day
enrol
exclud
patient
control
subject
includ
pathogen
detect
per
epic
studi
protocol
children
hospit
cap
combin
nasopharyng
np
oropharyng
op
swab
collect
within
hour
hospit
admiss
specimen
transfer
univers
transport
media
refriger
store
within
hour
bacteria
haemophilu
influenza
gramneg
bacteria
staphylococcu
aureu
streptococcu
anginosu
streptococcu
miti
streptococcu
pneumonia
streptococcu
pyogen
detect
cultur
blood
endotrach
aspir
bronchoalveolarlavag
specimen
pleural
fluid
pcr
whole
blood
pleural
fluid
chlamydophila
pneumonia
mycoplasma
pneumonia
detect
pcr
npop
swab
virus
adenoviru
adv
coronaviru
human
metapneumoviru
human
rhinoviru
hrv
human
influenza
parainfluenza
virus
hpiv
respiratori
syncyti
viru
detect
pcr
npop
swab
serolog
acuteand
convalescentphas
serum
except
human
rhinoviru
coronavirus
nasopharyng
op
swab
also
obtain
asymptomat
control
subject
elect
surgeri
oper
room
test
viral
pathogen
c
pneumonia
pneumonia
nasopharyng
op
swab
extract
use
qiaamp
viral
rna
extract
kit
per
manufactur
instruct
addit
oncolumn
dnase
treatment
wash
rnasefre
dnase
plu
buffer
rdd
qiagen
room
temperatur
minut
addit
wash
step
index
cdna
librari
prepar
truseq
rna
sampl
prep
kit
follow
manufactur
instruct
illumina
librari
quantifi
illumina
univers
librari
quantif
kit
kapa
biosystem
appli
biosystem
fast
realtim
pcr
system
appli
bioscienc
librari
size
qualiti
assess
high
sensit
dna
analysi
kit
agil
bioanalyz
agil
technolog
librari
sampl
combin
equimolar
ratio
final
concentr
nm
sequenc
batch
sampl
per
lane
hiseq
instrument
illumina
gener
averag
sequenc
read
base
pair
per
sampl
match
pairedend
read
concaten
ad
n
read
read
result
sequenc
analyz
taxonom
alignmentfre
rapid
interact
metagenom
sequenc
analysi
tool
microbi
identif
result
visual
http
taxonomeriobioio
taxa
read
assign
ignor
viral
taxa
phage
confirm
manual
map
sequenc
file
relev
refer
sequenc
geneiou
version
biomatt
compar
viral
sequenc
nation
center
biotechnolog
inform
nucleotid
databas
viral
taxa
identifi
base
read
consid
read
ident
match
sampl
within
batch
manual
analysi
protocol
previous
shown
produc
result
compar
us
food
drug
pcr
panel
combin
npop
swab
sampl
univers
transport
media
extract
use
either
manual
method
qiaamp
viral
rna
extract
kit
qiagen
autom
method
biosprint
one
kit
qiagen
kingfish
platform
thermo
accord
manufactur
instruct
panvir
group
pcr
assay
design
amplifi
known
potenti
novel
member
viral
familiesgenera
list
design
use
consensusdegener
hybrid
oligonucleotid
primer
codehop
principl
conserv
gene
region
analyt
sensit
copi
rna
virus
copi
dna
virus
per
reaction
sampl
total
nucleic
acid
test
broadli
reactiv
pvg
pcr
follow
viral
familiesgenera
adenovirida
anellovirida
arenavirida
astrovirida
bunyavirida
calicivirida
circovirida
coronavirida
flavivirida
flaviviru
herpesvirida
orthomyxovirida
influenza
virus
b
c
paramyxovirida
parvovirida
picornavirida
enteroviru
parechoviru
primer
target
human
rhinovirus
polyomavirida
reovirida
aquareoviru
orthoreoviru
orbiviru
rotaviru
seadornaviru
rhabdovirida
togavirida
alphaviru
picornavirida
pcr
target
subset
human
rhinovirus
firstround
reversetranscript
pcr
rna
virus
perform
superscript
iiiplatinum
taq
one
step
kit
invitrogen
secondround
pcr
perform
titanium
taq
clontech
kit
first
secondround
pcr
dna
virus
perform
hot
start
ex
taq
kit
takara
posit
neg
pcr
control
contain
mutationengin
synthet
rna
transcript
dna
amplicon
nucleasefre
water
respect
includ
run
polymeras
chain
reaction
product
visual
agaros
gel
posit
band
expect
size
strong
signal
without
addit
band
clean
use
exonucleas
new
england
biolab
shrimp
alkalin
phosphatas
roch
sampl
incub
minut
follow
minut
inactiv
exonucleas
shrimp
alkalin
phosphatas
posit
band
expect
size
addit
band
present
pcr
product
purifi
use
qiaquick
gel
extract
kit
qiagen
purifi
pcr
amplicon
sequenc
pcr
primer
direct
abi
prism
autom
capillari
sequenc
appli
biosystem
use
big
dye
cycl
sequenc
kit
life
technolog
first
assess
abil
rnaseq
pvg
pcr
detect
known
respiratori
pathogen
use
specimen
children
cap
n
asymptomat
control
n
subject
viral
atyp
bacteri
pathogen
detect
use
epic
studi
protocol
nasopharyng
op
specimen
analyz
rnaseq
pvg
pcr
describ
proport
put
pathogen
detect
method
individu
combin
determin
descript
statist
calcul
proport
compar
fisher
exact
test
appropri
assess
associ
viru
detect
diseas
compar
children
cap
asymptomat
control
subject
calcul
adjust
odd
ratio
aor
confid
interv
ci
use
approxim
exact
logist
regress
control
season
age
group
statist
analys
perform
use
r
r
foundat
statist
comput
approxim
exact
logist
regress
model
develop
use
elrm
packag
r
markov
chain
iter
burnin
iter
discard
conduct
infer
valid
rnaseq
pvg
pcr
method
detect
known
respiratori
pathogen
test
specimen
use
method
children
cap
n
asymptomat
control
subject
n
viral
atyp
bacteri
pathogen
detect
use
epic
studi
protocol
children
pneumonia
rnaseq
detect
pathogen
detect
epic
studi
test
pvg
pcr
detect
exclud
hrv
pneumonia
tabl
control
subject
proport
detect
rnaseq
pvg
pcr
exclud
hrv
tabl
combin
result
method
known
pathogen
patient
known
pathogen
control
subject
detect
tabl
show
sensit
specif
detect
known
pathogen
calcul
base
test
sampl
result
could
differ
calcul
entir
epic
studi
trend
toward
lower
sensit
control
subject
may
relat
lower
viral
load
asymptomat
children
note
sensit
lowest
adenoviru
method
rnaseq
detect
advposit
sampl
n
patient
n
control
subject
wherea
pvg
pcr
detect
adv
patient
control
subject
rna
sequenc
detect
hrv
pcrposit
specimen
wherea
pvg
pcr
detect
pneumonia
infect
detect
rnaseq
target
pvg
pcr
specimen
pathogen
detect
pcr
rnaseq
pvg
pcr
detect
previous
unrecogn
virus
children
cap
previous
unrecogn
virus
asymptomat
control
subject
figur
anellovirus
commonli
detect
virus
n
patient
n
control
subject
follow
human
herpesviru
n
patient
n
control
subject
human
herpesviru
n
patient
n
control
subject
virus
interest
human
bocaviru
hbov
n
patient
n
control
subject
astroviru
n
patient
n
control
subject
human
parechoviru
n
patient
n
control
subject
measl
viru
n
patient
human
virus
detect
children
pneumonia
control
subject
figur
tabl
testneg
use
epic
studi
protocol
patient
compar
control
subject
commonli
detect
virus
anellovirus
vs
aor
ci
vs
aor
ci
vs
aor
ci
human
bocaviru
detect
significantli
greater
proport
patient
control
subject
aor
ci
p
coxsackievirus
detect
patient
control
subject
associ
statist
signific
aor
ci
p
potenti
pathogen
commonli
detect
patient
control
subject
differ
statist
signific
hrva
aor
ci
p
aor
ci
p
addit
virus
detect
includ
epsteinbarr
viru
n
patient
n
control
subject
measl
viru
n
patient
polyomavirus
n
patient
hpv
type
n
patient
herp
simplex
viru
n
patient
rotaviru
n
patient
parvoviru
n
patient
n
control
subject
echoviru
n
control
subject
cytomegaloviru
cmv
n
patient
n
control
subject
human
parechoviru
n
patient
n
control
subject
cardiovirus
n
control
subject
commonli
detect
control
subject
patient
figur
show
proport
codetect
put
pathogen
detect
patient
detect
control
subject
codetect
monodetect
hbov
significantli
associ
cap
ci
children
cap
identifi
etiolog
virus
detect
method
rnaseq
pvg
pcr
supplementari
figur
control
subject
virus
detect
method
rnaseq
pvg
pcr
vast
major
virus
detect
pvg
pcr
anellovirus
combin
detect
patient
control
subject
supplementari
figur
patient
remain
virus
commonli
detect
method
rnaseq
compar
pvg
pcr
control
subject
remain
virus
frequent
detect
rnaseq
method
pvg
pcr
sampl
entir
viral
genom
could
determin
two
mismatch
identifi
revers
primer
bind
site
coxsackieviru
hrvc
genom
respect
failur
detect
virus
pgv
pcr
like
due
reduc
sensit
degener
pcr
primer
primer
mismatch
one
infant
cap
identifi
pathogen
epic
studi
protocol
c
trachomati
detect
rnaseq
patient
cap
potenti
bacteri
pathogen
identifi
figur
although
divers
set
bacteria
consist
upper
respiratori
tract
flora
detect
patient
flora
patient
domin
singl
gramneg
organ
patient
trisomi
pseudomona
fluorescen
domin
bacteri
sequenc
approxim
best
match
strain
access
number
patient
spina
bifida
chiari
malform
histori
aspir
pneumonia
approxim
bacteri
sequenc
origin
serratia
marcescen
best
match
strain
access
number
use
rnaseq
pvg
pcr
identifi
addit
virus
upper
respiratori
tract
specimen
children
hospit
clinic
radiograph
pneumonia
pathogen
identifi
despit
extens
test
cultur
molecular
serolog
method
human
bocaviru
coxsackievirus
hrvc
hrva
commonli
detect
children
cap
compar
control
subject
hbov
statist
common
control
subject
suggest
pathogen
may
play
etiolog
role
cap
make
etiolog
diagnosi
patient
pneumonia
import
understand
epidemiolog
provid
appropri
therapi
limit
unnecessari
use
antimicrobi
howev
extens
test
use
standard
approach
unabl
identifi
pathogen
approxim
children
approxim
adult
data
proofofconcept
studi
upper
respiratori
specimen
suggest
rnaseq
pvg
pcr
enabl
comprehens
pathogen
detect
compar
virusspecif
realtim
pcrbase
test
although
specimen
upper
respiratori
tract
collect
without
invas
procedur
use
identifi
viral
infect
limit
util
test
bacteri
pneumonia
detect
virus
studi
broadli
categor
group
known
respiratori
pathogen
virus
unclear
pathogen
opportunist
virus
pathogen
immunocompromis
host
virus
thought
play
pathogen
role
respiratori
tract
ill
among
known
respiratori
pathogen
detect
coxsackieviru
hrv
adv
hpiv
human
parechoviru
measl
viru
combin
detect
children
cap
coxsackieviru
hrv
adv
hpiv
measl
viru
commonli
detect
patient
control
subject
aor
possibl
due
overal
low
frequenc
detect
differ
reach
statist
signific
human
parechoviru
echoviru
caus
respiratori
tract
infect
detect
infrequ
patient
control
subject
aor
respect
patient
measl
viru
detect
show
sign
measl
vaccin
day
posit
rnaseq
day
posit
rnaseq
pvg
pcr
sampl
collect
suggest
detect
vaccin
strain
howev
low
number
sequenc
read
preclud
demonstr
examin
complet
viral
genom
cardiovirus
possibl
caus
respiratori
tract
infect
detect
control
subject
patient
human
bocaviru
commonli
detect
viru
among
children
cap
identifi
pathogen
n
human
bocaviru
detect
strongli
associ
cap
aor
ci
figur
three
infect
codetect
put
viral
pathogen
monodetect
hbov
significantli
associ
cap
ci
human
bocaviru
target
part
epic
studi
protocol
due
uncertainti
role
human
pathogen
human
bocaviru
parvoviru
dna
genom
detect
week
month
follow
acut
infect
make
difficult
demonstr
pathogen
even
welldesign
epidemiolog
studi
panvir
group
pcr
detect
hbov
dna
patient
asymptomat
control
subject
rna
sequenc
identifi
hbov
mrna
patient
asymptomat
control
subject
aor
ci
p
sequenc
read
span
splice
site
viral
capsid
mrna
confirm
mrna
rather
genom
dna
serv
sequenc
templat
data
shown
strong
associ
contrast
numer
pcrbase
studi
target
viral
genom
dna
suggest
detect
hbov
mrna
may
serv
marker
acut
ie
clinic
relev
infect
although
result
need
confirm
larger
studi
result
suggest
hbov
may
associ
cap
may
true
pathogen
human
herpesvirus
caus
respiratori
tract
infect
includ
pneumonia
immunocompromis
host
eg
hsv
cmv
parvoviru
frequent
detect
patient
control
subject
analysi
howev
children
sever
immunecompromis
condit
exclud
epic
studi
virus
frequent
detect
pvg
pcr
target
viral
genom
dna
rnaseq
absenc
detect
rna
activ
replic
unlik
detect
may
result
reactiv
latent
infect
rather
acut
infect
lastli
detect
number
virus
known
caus
respiratori
tract
infect
includ
ebv
anellovirus
polyomavirus
papillomaviru
detect
nasopharynx
andor
oropharynx
asymptomat
children
well
cap
patient
valid
testneg
group
consist
previou
report
detect
demonstr
power
comprehens
pathogen
detect
also
import
use
appropri
control
interestingli
detect
rate
dna
virus
much
higher
dnabas
pvg
pcr
rnaseq
possibl
rnabas
test
may
sensit
dna
virus
highlevel
replic
mrna
abund
although
rnaseq
pvg
pcr
provid
broadrang
detect
respiratori
virus
method
potenti
advantag
disadvantag
rna
sequenc
highli
unbias
demonstr
detect
diverg
enterovirus
identifi
pvg
pcr
enabl
identif
nonvir
pathogen
exemplifi
detect
pneumonia
c
trachomati
contrast
pvg
pcr
identifi
dna
virus
detect
rnaseq
may
due
part
shed
predominantli
viral
particl
contain
genom
dna
low
level
activ
replic
ie
product
mrna
upper
respiratori
tract
perform
nextgener
sequenc
rnaseq
dna
sequenc
might
increas
yield
dna
virus
bacteria
increas
financi
cost
hypothes
broadrang
pathogen
detect
enabl
identif
virus
part
comprehens
test
panel
eg
hbov
coxsackieviru
echoviru
human
parechoviru
genet
diverg
strain
escap
pcrbase
detect
seen
genet
divers
virus
eg
hrva
hrvc
unrecogn
bacteri
infect
eg
c
trachomati
addit
sequenc
data
analysi
describ
also
perform
de
novo
assembl
rnaseq
result
search
result
contigu
sequenc
conserv
protein
profil
data
children
cap
without
identifi
addit
put
pathogen
data
shown
despit
extens
effort
potenti
pathogen
still
detect
children
cap
unknown
etiolog
could
due
test
npop
swab
lower
respiratori
tract
sampl
prefer
detect
bacteri
fungal
pathogen
focu
viral
pathogen
inadequ
time
sampl
collect
polymicrobi
infect
caus
bacteri
fungal
pathogen
noninfecti
mimic
use
broadrang
method
may
provid
even
greater
benefit
adult
cap
pathogen
detect
use
convent
approach
find
also
highlight
limit
etiolog
diagnosi
cap
noninvas
sampl
exclud
highli
divers
virus
without
homolog
known
human
viral
pathogen
may
caus
cap
children
advanc
diagnosi
cap
like
requir
addit
sampl
well
hostbas
marker
infecti
process
may
help
confirm
infecti
etiolog
even
pathogen
directli
detect
